Vimarsana
Biggest News Aggregation in the World

Global Immunisation Division News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Global Immunisation Division. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Global Immunisation Division Today - Breaking & Trending Today

US CDC partners FG to reach 2.3m unvaccinated Nigerian children - Vimarsana News

US CDC partners FG to reach 2.3m unvaccinated Nigerian children

The United States Centres for Disease Control and Prevention in Nigeria has pledged to support the Federal Government in reaching zero-dose

Measles kills 136,000 kids every year – would you recognise symptoms in your child before it's too late? - Vimarsana News

Measles kills 136,000 kids every year – would you recognise symptoms in your child before it's too late?

Measles deaths across the world increased by 43 per cent in 2022

Nigeria among top ten countries where children miss their first - Vimarsana News

Nigeria among top ten countries where children miss their first

The World Health Organisation (WHO) and the U.S. Centres for Disease Control and Prevention (CDC) said on Thursday that Nigeria

Fighting From the Bottom Up: Community Mobilisation as a Viable Strategy in Combating Banditry in Nigeria – ACCORD - Vimarsana News

Fighting From the Bottom Up: Community Mobilisation as a Viable Strategy in Combating Banditry in Nigeria – ACCORD

Despite the attention garnered, banditry in Nigeria appears to be growing deadlier. These gangs, which initially only targeted rural areas, have significantly increased their operations to include major cities, interstates, and infrastructure.

Welcome To IANS Live - LatestNews - 1st clinical trial of measles vaccine delivery via stickers shows promise - Vimarsana News

Welcome To IANS Live - LatestNews - 1st clinical trial of measles vaccine delivery via stickers shows promise

The trial, evaluated the safety, immunogenicity, and acceptability of the commercially available MR vaccine from the Serum Institute of India and delivered via US-based life science company Micron Biomedical's microarray technology in adults, toddlers and infants, was presented at the MICRONEEDLES 2023 conference in Washington.In t